Defiance Daily Target 2X Long LLY ETF (LLYX)
ARCA ARCA Primary Summary
LLYX Chart
New Defiance Single-Stock ETF Tracks NOVO Nordisk Performance
Defiance ETFs added another single-stock ETF to its lineup, bringing the total number of 2x leveraged single-stock funds in its offering to five.
Defiance Lists Leveraged Eli Lilly ETF
On Thursday, Defiance ETFs rolled out its next leveraged fund, the Defiance Daily Target 2X Long LLY ETF (LLYX). The actively managed LLYX has a net expense ratio of 1.29%.
Defiance Daily Target 2X Long LLY ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Sarah Schmidt Wellington Wealth Strategies, LLC. | 1,345 | $24,411.75 | $33,611.55 | $9,199.8 | 37.69% |
Defiance Daily Target 2X Long LLY ETF (LLYX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Defiance Daily Target 2X Long LLY ETF ever had a stock split?
Defiance Daily Target 2X Long LLY ETF Profile
| ARCA Exchange | US Country |
Overview
The fund is designed for investors looking to amplify their exposure to specific financial markets, leveraging swap agreements with financial institutions. Through these agreements, the fund aims to seek returns that are twice the daily performance of the underlying security's shares, encapsulating a high-risk, high-reward strategy. It's important to note that the fund maintains a non-diverse portfolio, focusing on delivering substantial returns on a select number of investments rather than spreading risk across various assets. This approach is indicative of the fund's aggressive investment strategy, targeting investors who are comfortable with substantial volatility in pursuit of higher gains.
Products and Services
- Swap Agreements
- High Exposure Financial Instruments
These are contracts in which the fund and financial institutions agree to exchange the returns of a specific investment for another, typically for one day to periods longer than a year. This financial instrument is central to the fund's strategy, enabling it to aim for returns that are double the daily performance of the underlying securities.
The fund commits to maintaining at least 80% of its exposure to financial instruments designed to double the daily performance of its underlying securities. Such instruments may include, but are not limited to, derivatives, options, futures, and swap contracts, aligning with the fund's aggressive growth objectives.
